Concepedia

C. Hegedüs

CH

Statistics

Publications

2

Citations

241

H-Index

2

Active since

2006

Affiliations

Semmelweis University(Current)

C. Hegedüs is an author at Semmelweis University specializing in bcr-abl inhibitors, oncology, and tyrosine kinase inhibitors.

Publications per year

2006–2009

2

Publications

2

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti‐cancer effects and pharmacological properties

C. Hegedüs, Csilla Özvegy‐Laczka, Ágota Apáti et al. · British Journal of Pharmacology · 2009 · 227 citations · Full text

, , +15

Reduction of Bcr‐Abl Function Leads to Erythroid Differentiation of K562 Cells via Downregulation of ERK

Anna Brózik, Nicholas Casey, C. Hegedüs et al. · Annals of the New York Academy of Sciences · 2006 · 14 citations

, , +17

1–2 of 2